Applications of positron emission tomography imaging, intraoperative ultrasonography, magnetic resonance imaging, and angiography in the evaluation of renal masses

Current Urology Reports

Volumn 5, Issue 1, 2004, Pages 30-34

  Thompson, R Houston ^a   Hartman, Robert P ^b   Lowe, Val J ^b   Kawashima, Akira ^b   Leibovich, Bradley C ^b  

^a DEPARTMENT OF UROLOGY   (United States)

^b NONE

Author keywords

Magnetic Resonance Angiography; Partial Nephrectomy; Positron Emission Tomography; Renal Cell Carcinoma; Renal Vein

Indexed keywords

COMPUTER ASSISTED EMISSION TOMOGRAPHY; ECHOGRAPHY; HUMAN; KIDNEY TUMOR; MAGNETIC RESONANCE ANGIOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

HUMANS; KIDNEY NEOPLASMS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 2142755330     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-004-0008-8     Document Type: Article

References (25)

1. Pantuck AJ, Zisman A, Rauch MK, Belldegrun A: Incidental renal tumors. Urology 2000, 56:190–196. DOI: 10.1016/S0090-4295(00)00655-5
2. Smith S, Bosniak M, Megibow A, et al.: Renal cell carcinoma: earlier discovery and increased detection. Radiology 1989, 170:699–703.
3. Dechet C, Sebo T, Farrow G, et al.: Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol 1999, 162:1282–1284. DOI: 10.1016/S0022-5347(05)68265-1
4. Mathews D, Oz OK: Positron emission tomography in prostate and renal cell carcinoma. Curr Opin Urol 2002, 12:381–385. DOI: 10.1097/00042307-200209000-00003
5. Ramdave S, Thomas GW, Berlanghieri SU, et al.: Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 2001, 166:825–830. DOI: 10.1016/S0022-5347(05)65845-4
6. Bachor R, Kotzerke J, Gottfried HW, et al.: Positron emission tomography in diagnosis of renal cell carcinoma. Urologe A 1996, 35:146–150.
7. Miyakita H, Tokunaga M, Onda H, et al.: Significance of 18Ffluorodeoxyglucose positron emission tomography for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 expression in the cancer. Int J Urol 2002, 9:15–18. DOI: 10.1046/j.1442-2042.2002.00416.x
8. Safaei A, Figlin R, Hoh CK, et al.: The usefulness of F-18 deoxyglucose whole-body positron emission tomography for restaging of renal cell cancer. Clin Nephrol 2002, 57:56–62. This is the first article to effectively demonstrate that FDG PET is useful in characterizing anatomic lesions of unknown significance in patients with advanced renal cell carcinoma.
9. Lang O, Brouwers AH, Mergenthaler HG, et al.: Value of wholebody F-FDG-PET in metastatic renal cell carcinoma-correlation with tumor aggressiveness [Abstract]. Proceedings of the Society of Nuclear Medicine 47th Annual Meeting. St. Louis: June 3-June 7, 2000. J Nucl Med 2000, 41(suppl 5):117P.
10. Wolf JS: Evaluation and management of solid and cystic renal masses. J Urol 1998, 159:1120–1133. DOI: 10.1097/00005392-199804000-00002
11. Amendola MA, Bree RL, Pollack HM, et al.: Small renal cell carcinomas: resolving a diagnostic dilemma. Radiology 1998, 166:637–641.
12. Kletscher BA, Qian J, Bostwick DG, et al.: Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume, and deoxyribonucleic acid ploidy. J Urol 1995, 153:904–906. DOI: 10.1016/S0022-5347(01)67600-6
13. Polascik TJ, Meng MV, Epstein JI, et al.: Intraoperative sonography for the evaluation and management of renal tumors: experience with 100 patients. J Urol 1995, 154:1676–1680. DOI: 10.1016/S0022-5347(01)66748-X
14. Choyke PL, Pavlovich CP, Daryanani KD, et al.: Intraoperative ultrasound during renal parenchymal sparing surgery for hereditary renal cancers: a 10-year experience. J Urol 2001, 165:397–400. DOI: 10.1097/00005392-200102000-00010
15. Cheville JC, Lohse CM, Zincke H, et al.: Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003, 27:612–624. DOI: 10.1097/00000478-200305000-00005
16. Farrell MA, Charboneau WJ, DiMarco DS, et al.: Image-guided radiofrequency ablation of solid renal tumors. AJR Am J Roentgenol 2003, 180:1509–1513.
17. Kreft BP, Muller-Minny H, Sommer T, et al.: Diagnostic value of MR imaging in comparison to CT in the detection and differential diagnosis of renal masses: ROC analysis. Eur Rad 1997, 7:542–547. DOI: 10.1007/s003300050200
18. Bechtod RE, Zagoria RJ: Imaging approach to staging of renal cell carcinoma. Urol Clin North Am 1997, 24:507–522. DOI: 10.1016/S0094-0143(05)70399-2
19. Choyke PL: Detection and staging of renal cancer. Magn Reson Imaging Clin N Am 1997, 5:29–47.
20. Novick AC, Campbell SC: Renal tumors. In Campbell’s Urology, edn 8. Edited by Walsh PC. Philadelphia: WB Saunders; 2002:2672–2731.
21. Pretorius ES, Siegelman ES, Ramchandani P, et al.: Renal neoplasms amenable to partial nephrectomy: MR imaging. Radiology 1999, 212:24–34.
22. Levine E, King BF: Adult malignant renal parenchymal neoplasms. In Clinical Urography, edn 2. Edited by Polack HM, McClennan BL. Philadelphia: WB Saunders; 2000:1440–1559.
23. Kallman DA, King BF, Hattery RR, et al.: Renal vein and inferior vena cava tumor thrombus in renal cell carcinoma. J Comput Assist Tomogr 1992, 16:240–247. DOI: 10.1097/00004728-199203000-00012
24. Choyke PL, Walther MM, Wagner JR, et al.: Renal cancer: preoperative evaluation with dual-phase three-dimensional MR angiography. Radiology 1997, 205:767–771.
25. Goldfarb DA, Novick AC, Lorig R, et al.: Magnetic resonance imaging for assessment of vena caval tumor thrombi: a comparative study with venacavography and computerized tomography scanning. J Urol 1990, 144:1100–1104.